bioAffinity Technologies (BIAF) Stock: Buy, Sell, or Hold?
BIAF - bioAffinity Technologies, Inc. Common Stock
$7.95
-1.44 (-15.34%)
▼
5d:
-37.79%
30d:
+1581.83%
90d:
+387.73%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When BIAF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BIAF is down 37.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BIAF is down 37.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BIAF is currently trading at $7.95, which is considered slightly high relative to its 30-day fair value range of $-0.26 to $8.47.
Technical Outlook: Technically, BIAF is in a uptrend. Immediate support is located at $4.56, while resistance sits at $20.35. Short-term momentum is weak, with the stock down 15.3% recently.
Market Sentiment: BIAF scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $6.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BIAF is in a uptrend. Immediate support is located at $4.56, while resistance sits at $20.35. Short-term momentum is weak, with the stock down 15.3% recently.
Market Sentiment: BIAF scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $6.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$-0.26 -
$8.47
Company Quality Score
33/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
21.1%
All Signals
- BEARISH: Weak technical setup (0/100)
- BEARISH: Downward momentum (-15.3%)
- BEARISH: Trading 24.5% above Wall St target ($6.00)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$-0.26 -
$8.47
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.56
Resistance Level
$20.35
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.98
Wall Street Target
$6.00
(-24.5%)
Revenue Growth (YoY)
19.0%
Profit Margin
-257.3%
Share & Embed Analysis
Last updated: September 13, 2026 9:10 AM ET
Data refreshes hourly during market hours. Next update: 10:10 AM
Data refreshes hourly during market hours. Next update: 10:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIAF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$645 | 51 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$229 | 49 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 49 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$344 | 47 HOLD |
